Empagliflozin and Sympathetic Nerve Traffic

NCT03254849 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Empagliflozin
DRUG: Hydrochlorothiazide 25 mg

Sponsor

Profil Institut für Stoffwechselforschung GmbH